Research Output per year
Research Output per year
Fingerprint
Dive into the research topics where Vivien Yin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
-
Checkerboard: a Bayesian efficacy and toxicity interval design for phase I/II dose-finding trials
Yin, J. & Yuan, Y., 2020, (Accepted/In press) In: Journal of Biopharmaceutical Statistics.Research output: Contribution to journal › Article › peer-review
-
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
Salem, M. E., Yin, J., Goldberg, R. M., Pederson, L. D., Wolmark, N., Alberts, S. R., Taieb, J., Marshall, J. L., Lonardi, S., Yoshino, T., Kerr, R. S., Yothers, G., Grothey, A., Andre, T., De Gramont, A. & Shi, Q., Apr 2020, In: Annals of Oncology. 31, 4, p. 480-486 7 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma
Xie, H., Liu, J., Yin, J., Ogden, J. R., Mahipal, A., McWilliams, R. R., Truty, M. J., Bekaii-Saab, T. S., Petersen, G. M., Jatoi, A., Hubbard, J. M. & Ma, W. W., Nov 1 2020, In: Oncologist. 25, 11, p. e1681-e1690Research output: Contribution to journal › Article › peer-review
Open Access -
Survival benefit of combination chemotherapy in elderly patients with metastatic pancreatic ductal adenocarcinoma
Xie, H., Liu, J., Ogden, J. R., Yin, J., Jatoi, A., Hubbard, J. M., McWilliams, R. R., Mahipal, A., Petersen, G. M., Bekaii-Saab, T. S. & Ma, W. W., Aug 1 2020, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 43, 8, p. 586-590 5 p.Research output: Contribution to journal › Article › peer-review
-
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination
Carr, R. M., Duma, N., McCleary-Wheeler, A. L., Almada, L. L., Marks, D. L., Graham, R. P., Smyrk, T. C., Lowe, V., Borad, M. J., Kim, G., Johnson, G. B., Allred, J. B., Yin, J., Lim, V. S., Bekaii-Saab, T., Ma, W. W., Erlichman, C., Adjei, A. A. & Fernandez-Zapico, M. E., Sep 2020, In: Pancreatology. 20, 6, p. 1115-1122 8 p.Research output: Contribution to journal › Article › peer-review